News

Inorganic Ventures acquires PURE Analytical Laboratories, Combining Unique Capabilities for Precision Manufacturing

Two privately held specialty chemical firms that provide high-purity materials and services for chemical applications, from renewable energy to food and beverages and consumer safety, are combining their capabilities to serve new and expanding precision markets.

IV Labs Inc., the parent company of Inorganic Ventures, has acquired PURE Analytical Laboratories, one of the few companies that produces ultra-high purity formulations of most of the metals on the periodic table. Inorganic Ventures, a manufacturer of certified reference materials (CRMs), provides some of the highest levels of accuracy, certainty, and traceability, for quality control and analysis of impurities—along with a robust education and training program for scientists in the field.  PURE produces ultra-high purity starting materials, while Inorganic Ventures uses the materials to formulate precise custom standards and produce precision custom materials.

The combined expertise and resources will bolster IV Labs’ research and development program focused on developing new ultra-high purity products for emerging technologies and for reducing processing requirements for a wide range of existing markets, including electronics, transportation, pharmaceutical and food and beverage. “We are developing products and services beyond our traditional CRM market, that are based on our expertise in precision chemistry,” said Christopher Gaines, CEO of IV Labs and Inorganic Ventures.

The acquisition will also ensure that IV Labs’ spinoff venture, MERGE Chemistry, has a reliable, domestic source of precious metals and rare earth elements that play a critical role in the supply chain of current and next generation battery technologies.

Terms of the transaction were not disclosed; both firms are privately held.

Effective today, PURE will continue to operate from its existing headquarters in Feasterville, Pennsylvania, and continue to serve its customers worldwide as a subsidiary of IV Labs, of Christiansburg, Virginia.

All 100+ employees of both Inorganic Ventures and PURE Analytical Laboratories will be retained at their current locations.

Benefits of the transaction include:

  • Deeper technical expertise.
  • Seamless customer services.
  • Development of next-generation materials for emerging technologies.
  • Ability to produce new, previously unseen, purity levels on starter products.
  • Improved instrumentation capabilities and lower detection limits, thanks to cleaner CRMs.

Gaines will lead the combined company. Erik Miller, founder and CEO of PURE, will become chief strategy officer of the expanded IV Labs family of companies and retain part ownership of PURE.

“We are very excited to welcome the PURE team to the family and look forward to working together to support emerging technologies and the growing critical needs for high-purity materials,” Gaines explained. “Erik’s team are experts in high-purity materials: both sourcing and cleaning them. It’s a huge niche expertise.”

Miller is looking forward to working more closely with IV Labs. “It’s a team I trust, with a shared vision and similar corporate culture,” he said. “Now, we are in the position of holding proprietary technology in a sector that grows more critical as material needs grow more precise. Our joining IV positions us to continue to improve our products as industry needs change and to pursue some big opportunities in emerging technologies. There has never been a time like this.”

Learn more here.

Recent News

07/23/2026

Activation Capital Expands the Bio+Tech Center, Doubling Laboratory Capacity to Strengthen Virginia’s Life Sciences Entrepreneurship and Innovation Ecosystem

Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, today announced an expansion of its Bio+Tech Center to support the continued growth of life sciences entrepreneurship across the region. Activation Capital’s Bio+Tech Center is a life sciences incubator located within the Virginia Bio+Technology Research Park. Serving as both a physical and programmatic

07/22/2026

Epidarex Announces Leadership Appointments

With the launch of our latest fund, Epidarex Capital IV, LP, we are pleased to announce several promotions. As we continue to grow and deepen our impact across the US and UK life science ecosystems, recognizing and elevating exceptional talent within our team is a vital part of that journey. These transitions reflect our continued

07/22/2026

Phlow Corp. Appoints Sripathy Venkatraman, Ph.D, As Chief Scientific Officer

Phlow Corp., a U.S.-based advanced pharmaceutical contract development and manufacturing organization (CDMO), dedicated to strengthening the nation’s pharmaceutical supply chain and protecting America’s medicine cabinet, today announced the appointment of Sripathy Venkatraman, Ph.D., MBA, as Chief Scientific Officer. Venkatraman brings more than 25 years of experience in pharmaceutical development, process chemistry, manufacturing, and scientific leadership. He